Ze-Qi Xu
Fondatore presso Synchem, Inc.
Posizioni attive di Ze-Qi Xu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Synchem, Inc.
Synchem, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Formosa Laboratories, Inc., Synchem-Formosa is a company that engages in research and development of organic synthesis, medicinal chemistry, and pharmaceuticals. The company is based in Elk Grove Village, IL. The company was founded by Daniel Fang and Ze-Qi Xu. The CEO is W. Paul Mar. Synchem-Formosa was acquired by Formosa Laboratories, Inc. on June 03, 2024. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 | - |
Fondatore | 01/01/1997 | - |
Storia della carriera di Ze-Qi Xu
Precedenti posizioni note di Ze-Qi Xu
Società | Posizione | Inizio | Fine |
---|---|---|---|
ADVANCED LIFE SCIENCES HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2002 | 05/05/2011 |
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Corporate Officer/Principal | 01/01/2000 | 01/09/2002 |
Formazione di Ze-Qi Xu
Shanghai Jiao Tong University | Graduate Degree |
Jiangxi Normal University | Undergraduate Degree |
Shanghai Institute of Organic Chemistry | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Cina | 4 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Settori
Consumer Services | 4 |
Commercial Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Commercial Services |
Synchem, Inc.
Synchem, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Formosa Laboratories, Inc., Synchem-Formosa is a company that engages in research and development of organic synthesis, medicinal chemistry, and pharmaceuticals. The company is based in Elk Grove Village, IL. The company was founded by Daniel Fang and Ze-Qi Xu. The CEO is W. Paul Mar. Synchem-Formosa was acquired by Formosa Laboratories, Inc. on June 03, 2024. | Commercial Services |
- Borsa valori
- Insiders
- Ze-Qi Xu
- Esperienza